Supported by phase 3 OASIS-4 data, elinzanetant significantly reduced daily hot flash frequency in women receiving endocrine therapy for HR-positive breast cancer.

SM-AML can remain occult until cytoreduction shows MC proliferation, highlighting a potential role for SM evaluation in KIT-positive AML.

Cancer survivors are less likely to be physically active than adults without a cancer history, although physical activity (PA) increased in cancer survivors from 2018 to 2024, according to a study ...

A systematic review and meta-analysis evaluated qualitative evidence on the experiences of MBC survivors to understand how they cope with associated challenges.

A longitudinal study assessed cognitive trajectories in older and younger adults receiving CAR T-cell therapy for large B-cell lymphoma.

In this study, researchers examined approval and fill rates of specialty prescriptions for blood cancers among Medicare and commercially insured patients.

A chemotherapy-free, response-adapted regimen of frontline mosunetuzumab achieved high complete response rates and durable remission in patients with untreated FL or MZL.

For childhood cancer survivors (CCSs) of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin lymphoma (NHL), mental distress, fatigue, and executive function (EF) ...

A global study reveals that second-hand smoke exposure caused 1.66 million deaths in 2023, highlighting persistent risks for women and children.

A cross-sectional study evaluated oncology nurses' readiness, knowledge, and confidence in incorporating genomics into practice to identify educational needs for cancer care.

A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.